Report Overview
Q2, 2010
This primer – designed, executed and analyzed by research professionals from the drug development and commercialization industry – sheds light on prescribers’ views of biosimilars. It is based on interviews with 264 physicians in the United States and Western Europe. Respondents provided their beliefs, attitudes, intentions, and expectations on a number of biosimilar related topics including:
- Regulatory issues
- Safety and efficacy
- Prescribing / Pricing
- Development / Testing rigor
- Differences between “generic” and “novel” manufacturers
What you will learn:
Sponsors and service providers can rely on this report to provide an important perspective on their development and commercialization strategies for Biosimilar products
Report Contents:
- Regulatory Awareness
- Safety and Efficacy
- Perceptions of Generic and Innovator Companies
- Prescribing Behavior